BlackRock’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$466M Buy
3,608,322
+20,167
+0.6% +$2.9M 0.01% 1160
2025
Q4
$512M Buy
3,588,155
+66,564
+2% +$8.92M 0.01% 1087
2025
Q3
$422M Sell
3,521,591
-41,477
-1% -$5.26M 0.01% 1205
2025
Q2
$471M Sell
3,563,068
-16,054
-0.4% -$2.18M 0.01% 1101
2025
Q1
$497M Sell
3,579,122
-108,488
-3% -$16.8M 0.01% 1041
2024
Q4
$572M Buy
3,687,610
+38,014
+1% +$6.43M 0.01% 990
2024
Q3
$665M Buy
3,649,596
+398,609
+12% +$59M 0.01% 871
2024
Q2
$386M Buy
3,250,987
+656,099
+25% +$69M 0.01% 1175
2024
Q1
$278M Buy
2,594,888
+36,246
+1% +$3.6M 0.01% 1430
2023
Q4
$255M Buy
2,558,642
+830,747
+48% +$81.2M 0.01% 1490
2023
Q3
$206M Buy
1,727,895
+7,942
+0.5% +$1.19M 0.01% 1525
2023
Q2
$306M Sell
1,719,953
-31,091
-2% -$5.7M 0.01% 1274
2023
Q1
$289M Sell
1,751,044
-36,890
-2% -$6.35M 0.01% 1295
2022
Q4
$282M Buy
1,787,934
+56,567
+3% +$8.61M 0.01% 1271
2022
Q3
$261M Sell
1,731,367
-8,229
-0.5% -$1.37M 0.01% 1280
2022
Q2
$286M Buy
1,739,596
+65,589
+4% +$12.6M 0.01% 1263
2022
Q1
$373M Sell
1,674,007
-12,848
-0.8% -$2.88M 0.01% 1191
2021
Q4
$400M Buy
1,686,855
+35,823
+2% +$8.37M 0.01% 1217
2021
Q3
$385M Sell
1,651,032
-16,195
-1% -$3.4M 0.01% 1193
2021
Q2
$343M Sell
1,667,227
-76,081
-4% -$15.7M 0.01% 1353
2021
Q1
$358M Buy
1,743,308
+82,394
+5% +$17.4M 0.01% 1303
2020
Q4
$356M Sell
1,660,914
-318
-0% -$61.7K 0.01% 1157
2020
Q3
$304M Sell
1,661,232
-42,569
-2% -$8.01M 0.01% 1063
2020
Q2
$314M Buy
1,703,801
+26,015
+2% +$5.17M 0.01% 1023
2020
Q1
$339M Sell
1,677,786
-40,445
-2% -$7.79M 0.02% 816
2019
Q4
$322M Buy
1,718,231
+16,728
+1% +$2.88M 0.01% 1140
2019
Q3
$272M Buy
1,701,503
+143,186
+9% +$28.5M 0.01% 1176
2019
Q2
$393M Buy
1,558,317
+72,346
+5% +$16.8M 0.02% 926
2019
Q1
$356M Buy
1,485,971
+12,345
+0.8% +$2.96M 0.02% 982
2018
Q4
$338M Buy
1,473,626
+42,373
+3% +$10.4M 0.02% 902
2018
Q3
$405M Buy
1,431,253
+109,396
+8% +$32M 0.02% 910
2018
Q2
$388M Sell
1,321,857
-321,354
-20% -$87.8M 0.02% 930
2018
Q1
$415M Sell
1,643,211
-236,663
-13% -$55.6M 0.02% 820
2017
Q4
$406M Buy
1,879,874
+62,605
+3% +$12.7M 0.02% 831
2017
Q3
$338M Buy
1,817,269
+36,293
+2% +$6.33M 0.02% 938
2017
Q2
$307M Buy
1,780,976
+11,046
+0.6% +$1.77M 0.02% 979
2017
Q1
$270M Buy
1,769,930
+1,767,900
+87,089% +$258M 0.01% 1050
2016
Q4
$299K Sell
2,030
-233
-10% -$33.7K ﹤0.01% 1912
2016
Q3
$286K Buy
2,263
+133
+6% +$16K ﹤0.01% 1970
2016
Q2
$240K Sell
2,130
-2,247
-51% -$233K ﹤0.01% 1997
2016
Q1
$455K Sell
4,377
-3,090
-41% -$295K ﹤0.01% 1578
2015
Q4
$841K Sell
7,467
-7,238
-49% -$800K ﹤0.01% 1384
2015
Q3
$1.61M Buy
14,705
+1,710
+13% +$183K ﹤0.01% 1120
2015
Q2
$1.24M Buy
12,995
+1,813
+16% +$169K ﹤0.01% 1276
2015
Q1
$1.04M Buy
11,182
+10,818
+2,972% +$946K ﹤0.01% 1335
2014
Q4
$30K Hold
364
﹤0.01% 2177
2014
Q3
$23K Hold
364
﹤0.01% 2258
2014
Q2
$22K Sell
364
-27
-7% -$1.59K ﹤0.01% 2326
2014
Q1
$23K Hold
391
﹤0.01% 2292
2013
Q4
$25K Hold
391
﹤0.01% 2254
2013
Q3
$27K Hold
391
﹤0.01% 2117
2013
Q2
$28K Buy
+391
New +$25.9K ﹤0.01% 2122

Other funds holding ICUI

BlackRock's ICUI Position: Q1 2026 in Review

BlackRock increased its ICU Medical (ICUI) stake by 0.56% in Q1 2026, buying an estimated $2.9M and bringing the position to 3,608,322 shares worth $466M. The position accounts for 0.01% of the portfolio, ranked #1160.

BlackRock first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $665M in Q3 2024. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • BlackRock held 3,608,322 shares of ICU Medical worth $466M as of Q1 2026.
  • BlackRock bought 20,167 ICU Medical shares in Q1 2026, an estimated $2.9M.
  • ICU Medical made up 0.01% of BlackRock's portfolio in Q1 2026, its #1160 holding.
  • BlackRock first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • BlackRock's ICU Medical position peaked at $665M in Q3 2024.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.